| Literature DB >> 34019268 |
Lillian Truong1, Yun-Min Zheng1, Sharath Kandhi2, Yong-Xiao Wang3.
Abstract
Inflammatory signaling is a major component in the development and progression of many lung diseases, including asthma, chronic obstructive pulmonary disorder (COPD), and pulmonary hypertension (PH). This chapter will provide a brief overview of asthma, COPD, and PH and how inflammation plays a vital role in these diseases. Specifically, we will discuss the role of reactive oxygen species (ROS) and Ca2+ signaling in inflammatory cellular responses and how these interactive signaling pathways mediate the development of asthma, COPD, and PH. We will also deliberate the key cellular responses of pulmonary arterial (PA) smooth muscle cells (SMCs) and airway SMCs (ASMCs) in these devastating lung diseases. The analysis of the importance of inflammation will shed light on the key questions remaining in this field and highlight molecular targets that are worth exploring. The crucial findings will not only demonstrate the novel roles of essential signaling molecules such as Rieske iron-sulfur protein and ryanodine receptor in the development and progress of asthma, COPD, and PH but also offer advanced insight for creating more effective and new therapeutic targets for these devastating inflammatory lung diseases.Entities:
Keywords: Asthma; Ca2+ signaling; Chronic obstructive pulmonary disorder; Contraction; Inflammation; Nicotine; Pulmonary hypertension; Reactive oxygen species; Remodeling; Rieske iron-sulfur protein
Year: 2021 PMID: 34019268 DOI: 10.1007/978-3-030-68748-9_9
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622